Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

  • krnfreak99 krnfreak99 Mar 21, 2013 11:15 AM Flag

    Phase 1 and pre-clinical drug prospects

    ASG-5ME in particular. I'm still kind of baffled that a biotech with its current market cap can be so undercovered while much smaller names will have more analyst ratings/reports. It's really frustrating for someone that has an interest in biotechnology (not to the extent some of you have, I'm guessing) but does not have the academic background to interpret some of the results (I know I know, maybe I shouldn't be investing in this but it's worked out for me in the two years I've owned it now in addition to some others). What do the rest of you think about them?

 
SGEN
36.13-0.44(-1.20%)Apr 17 4:00 PMEDT